Cullen/Frost Bankers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Buy |
297
+147
| +98% | +$8.08K | ﹤0.01% | 951 |
|
|
2025
Q1 | $10.6K | Buy |
150
+67
| +81% | +$4.74K | ﹤0.01% | 936 |
|
|
2024
Q4 | $5.46K | Buy |
83
+70
| +538% | +$4.6K | ﹤0.01% | 984 |
|
|
2024
Q3 | $914 | Hold |
13
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q2 | $1.07K | Buy |
+13
| New | +$1.07K | ﹤0.01% | 1180 |
|
|
2023
Q2 | – | Sell |
-4
| Closed | -$389 | – | 1142 |
|
|
2023
Q1 | $389 | Hold |
4
| – | – | ﹤0.01% | 1174 |
|
|
2022
Q4 | $414 | Hold |
4
| – | – | ﹤0.01% | 1086 |
|
|
2022
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1143 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$1K | – | 1071 |
|
|
2020
Q3 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 1061 |
|
|
2020
Q2 | – | Sell |
-115
| Closed | -$10K | – | 1095 |
|
|
2020
Q1 | $10K | Sell |
115
-20
| -15% | -$1.74K | ﹤0.01% | 719 |
|
|
2019
Q4 | $11K | Sell |
135
-126
| -48% | -$10.3K | ﹤0.01% | 880 |
|
|
2019
Q3 | $18K | Buy |
261
+250
| +2,273% | +$17.2K | ﹤0.01% | 740 |
|
|
2019
Q2 | $1K | Sell |
11
-41
| -79% | -$3.73K | ﹤0.01% | 982 |
|
|
2019
Q1 | $5K | Buy |
+52
| New | +$5K | ﹤0.01% | 802 |
|